Adaptive Biotechnologies plans to release its complete fourth quarter and full year 2025 financial results during its earnings call in February 2026. 1 Excludes Digital Biotechnologies, Inc. cash and ...
New approach focuses on fixing the operational and technology failures that cause customer dissatisfaction You don’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback